52
The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.Original Article
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech
previous post